Natalie Levy, MD

In my role as Director of Bellevue’s Primary Care Diabetes Program I am focused on improving the care of our patients with Type 2 Diabetes (T2DM). This involves continual awareness, dissemination and thoughtful incorporation of new and exciting guidelines that not only focus on the control of blood sugar, but on the use of medications that decrease cardiovascular and renal events and on technologies that make T2DM less burdensome. I have a special interest in designing practical, high impact workflows and programs that utilize a team approach and that make sense for safety-net clinics (which always needs to optimize the use of resources). I also run our Primary Care Hypertension Program and also focus much attention on Dyslipidemia and Metabolic Syndrome, always with a strong center of attention on Lifestyle Medicine.

Some highlights of our Primary Care Diabetes Program include: Creative workflows for supporting patients through the start of glucagon-like peptide-1 receptor agonists (GLP1-RAs) and Continuous Glucose Monitors; Text Message Based Programs for the remote titration of Injectable Diabetes Medications; Clinical programs embedded right in the medical clinic for supporting T2DM management like The A1c Clinic (general internists providing consultant T2DM care for our most complex patients), The Pharm D Collaborative Drug Therapy Management Program (providing collaborative T2DM care in partnership with the Primary Medical Doctor), The 3-7 Day Program where the Diabetes Nursing Team reaches out to patients 3-7 days after a T2DM Medication change to learn if the change was made and if not to troubleshoot barriers to implementation; Robust outreach programs with Advanced Practice Provider staffed Recall Clinics to bring lost to follow-up patients back in for expedited, focused T2DM Care.  I currently support work by Primary Investigator Dr. John Dodson on his NIH funded grant called Better-BP, evaluating the use of financial incentives to improve blood pressure medication adherence.